State Of Wyoming Tcr2 Therapeutics Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.58 - $8.34 $2,940 - $5,354	-642 Closed	0 $0
Q3 2021 Feb 11, 2022	SELL	$8.44 - $18.35 $4,034 - $8,771	-478 Reduced 42.68%	642 $5,000
Q2 2021 Feb 11, 2022	BUY	$16.41 - $24.71 $12,668 - $19,076	772 Added 221.84%	1,120 $18,000
Q1 2021 Feb 08, 2022	BUY	$20.38 - $34.07 $7,092 - $11,856	348 New	348 $8,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.